Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel (CLARA)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Janssen Cilag S.A.S.
ClinicalTrials.gov Identifier:
NCT00989300
First received: October 2, 2009
Last updated: September 19, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)